Thoracic Aortic Aneurysm
45
13
19
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
4.4%
2 terminated out of 45 trials
84.6%
-1.9% vs benchmark
4%
2 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (45)
MBA Early Feasibility Study
HEART: Pilot Randomized Controlled Trial
Terumo Aortic Global Endovascular Registry
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
Thoraflex Hybrid and Relay Extension Post-Approval Study
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Effects of Exercise on Thoracic Aneurysms
Impact of Right Atrial Occlusion on TEVAR Outcomes
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
Active Thoracic Compromised Distal LANding in TEvar
Mid- and Long-term Outcomes of Custom-made Aortic Devices
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis